Médica neumóloga, salud pública 🫁 Autora de 2 libros 📚 ¡Hoy es un buen día para dejar de fumar! Instagram @ consultasdrazaidaroam #VenezolanosEnArgentina
Argentina
- Tweets 11,143
- Following 1,510
- Followers 1,695
- Likes 52,019
Pinned Tweet
Gracias @autoresdearg por publicar mi Ebook ¡Hoy es un buen día para dejar de fumar!. Disponible en Amazon amazon.com/dp/B0D72HMKD3
AppleBooks books.apple.com/ar/book/hoy-…
GooglePlay play.google.com/store/books/…
«Si ayudo a una sola persona a tener esperanza, no habré vivido en vano. MLK»
12
16
33
3,709
Dra. Zaida Roa Moreno. retweeted
ERJOR: In chronic airway diseases, initiation of inhaled antibiotic therapy is largely driven by microbiological isolation, and occurs both in stable conditions and during periods of clinical instability, with exacerbations remaining an important trigger bit.ly/3OPpUJv
9
13
1,205
Dra. Zaida Roa Moreno. retweeted
ERJ Open Research: Among patients with severe pulmonary hypertension associated with COPD, acute pulmonary vasoreactivity identified a subgroup with better haemodynamic response to approved PAH therapies and long-term survival bit.ly/4tt1y7h
2
7
11
1,482
"«La carcinogenicidad de los cigarrillos electrónicos: una evaluación cualitativa de riesgos».. Título original:
"carcinogenicity of e-cigarettes: a qualitative risk assessment". academic.oup.com/carcin/arti…
1
2
2
94
Dra. Zaida Roa Moreno. retweeted
Airway mucus plugs in asthma and #COPD: pathobiology, imaging, and implications for clinical trials
doi.org/10.1093/ajrccm/aamag… @atscommunity
1
23
44
3,157
Dra. Zaida Roa Moreno. retweeted
Defining disease stability in #COPD: evidence from phase 3 clinical trials
doi.org/10.1093/ajrccm/aamag… @atscommunity
5
10
1,163
Dra. Zaida Roa Moreno. retweeted
Bronchiectasis is driven by dynamic host–microbiome interactions, not single pathogens. Integrating microbial and immune multi-omics can define actionable endotypes, enabling precision therapy and accelerating translation from discovery to clinical care. bit.ly/4xfavDv
1
26
49
2,982
Dra. Zaida Roa Moreno. retweeted
Astegolimab for COPD with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials
doi.org/10.1093/ajrccm/aamag… @atscommunity
8
13
5,268
Dra. Zaida Roa Moreno. retweeted
Dupilumab in #COPD: a pooled analysis of emergency department visits, hospital admissions, and systemic corticosteroid use. @atscommunity
doi.org/10.1093/ajrccm/aamag…
11
19
2,361
Dra. Zaida Roa Moreno. retweeted
Despite the growing interest in the use of biologics to treat acute exacerbations, the evidence base remains limited. The latest CHEST Commentary discusses where evidence exists and where there are gaps.
Read more in the September issue of the journal CHEST®: hubs.la/Q04x26Bv0
#MedEd #JournalCHEST #Asthma
1
4
11
1,664
Dra. Zaida Roa Moreno. retweeted
ERJ Open Research: FENO variation patterns identify high-risk COPD phenotypes. Two high-FENO subtypes predicted future exacerbations and inflammatory instability – not absolute FENO – was the key signal, supporting FENO-based precision risk stratification. bit.ly/4vepb4T
2
14
26
1,944
Dra. Zaida Roa Moreno. retweeted
🫁It's coming soon - save the date 25th September 2026 World Lung Day! 🫁
#worldlungday
4
7
204
Dra. Zaida Roa Moreno. retweeted
A new review by Vickram Tejwani and colleagues provides an overview of biological treatments in asthma and COPD, their clinical applications, and the role of biomarkers in guiding treatment decisions.
Read the full review in BMJ Medicine: bit.ly/4gLhU63
1
1
306
Dra. Zaida Roa Moreno. retweeted
CT-detected mucus plugs in COPD are linked to increased small airway resistance and ventilation heterogeneity on oscillometry. doi.org/10.1093/ajrccm/aamag…
@BWHPulmCCM
8
11
1,475
Dra. Zaida Roa Moreno. retweeted
Type 2 inflammatory multimorbidities are present in COPD and their prevalence increases with BEC, though they are generally less prevalent than in asthma. This information is relevant to discussions about the presence and importance of type 2 inflammation. bit.ly/4sx2RSa
10
20
1,895
Dra. Zaida Roa Moreno. retweeted
ERJ Open Research: Circulating annexin A1 levels are elevated during COPD exacerbations, and correlate with systemic inflammation and impaired lung function, supporting its potential as a biomarker of disease severity bit.ly/47wBsI9
3
13
3,161
Dra. Zaida Roa Moreno. retweeted
PS-OCT maps out the heterogeneous distribution of airway smooth muscle remodelling in patients with asthma, providing insights that were previously only accessible post mortem. PS-OCT can support the development of new therapies to reduce smooth muscle. bit.ly/4cgeLdQ
10
20
1,415
Dra. Zaida Roa Moreno. retweeted
Is monitoring drug levels clinically useful in the management of patients with nontuberculous mycobacterial pulmonary disease?
Read the Counterpoint article arguing against the practice, and the opposing viewpoint, in the August issue of the journal CHEST®: hubs.la/Q04q8K-L0
#MedEd #JournalCHEST
3
3
1,461
Dra. Zaida Roa Moreno. retweeted
This first study integrating gene expression and methylation omics from sarcoidosis CD4+ BAL cells identified risk-associated T-cell immunophenotypes, novel targets and others previously associated with sarcoidosis, validating some in a separate group bit.ly/4q9Kwct
7
11
1,365
Dra. Zaida Roa Moreno. retweeted
Interleukin-6 is a mediator of therapeutic efficacy in acute lung injury
doi.org/10.1093/ajrccm/aamag…
@atscommunity
8
13
1,384
Dra. Zaida Roa Moreno. retweeted
COMSA-MEWS was developed and tested as a five-domain quantitative sum score algorithm to increase granularity in the assessment of response to biologics in severe asthma. This scale has the potential to improve asthma management and clinical research. bit.ly/3OzEtjM
9
11
1,324